- Home
- INVA vs PSEC Comparison
INVA vs PSEC Comparison
Compare INVA & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- PSEC
- Stock Information
- Founded
- INVA 1996
- PSEC 2004
- Country
- INVA United States
- PSEC United States
- Employees
- INVA N/A
- PSEC 8
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- PSEC Finance/Investors Services
- Sector
- INVA Health Care
- PSEC Finance
- Exchange
- INVA Nasdaq
- PSEC Nasdaq
- Market Cap
- INVA 1.1B
- PSEC 1.2B
- IPO Year
- INVA 2004
- PSEC 2004
- Fundamental
- Price
- INVA $17.71
- PSEC $2.65
- Analyst Decision
- INVA Buy
- PSEC Sell
- Analyst Count
- INVA 5
- PSEC 1
- Target Price
- INVA $35.60
- PSEC $2.50
- AVG Volume (30 Days)
- INVA 767.7K
- PSEC 3.3M
- Earning Date
- INVA 11-06-2025
- PSEC 11-07-2025
- Dividend Yield
- INVA N/A
- PSEC 20.30%
- EPS Growth
- INVA N/A
- PSEC N/A
- EPS
- INVA 0.53
- PSEC N/A
- Revenue
- INVA $370,229,000.00
- PSEC $719,436,000.00
- Revenue This Year
- INVA $7.98
- PSEC N/A
- Revenue Next Year
- INVA $11.60
- PSEC N/A
- P/E Ratio
- INVA $32.96
- PSEC N/A
- Revenue Growth
- INVA 12.02
- PSEC N/A
- 52 Week Low
- INVA $16.52
- PSEC $2.57
- 52 Week High
- INVA $22.00
- PSEC $5.28
- Technical
- Relative Strength Index (RSI)
- INVA 46.40
- PSEC 40.15
- Support Level
- INVA $17.45
- PSEC $2.68
- Resistance Level
- INVA $18.45
- PSEC $2.82
- Average True Range (ATR)
- INVA 0.50
- PSEC 0.07
- MACD
- INVA 0.12
- PSEC -0.01
- Stochastic Oscillator
- INVA 52.42
- PSEC 3.21
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.